CohBar, Inc.
NASDAQ: CWBR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pinchas Cohen Dean,
- Employees
- 9
- Headquarters
- Menlo Park, United States
- IPO year
- 2017
- Market cap
- $1.2M
- Website
- https://www.cohbar.com
Loading CWBR…
Loading profile data…Frequently asked questions about CWBR
What does CohBar, Inc. (CWBR) do?
CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum...
Where does CWBR trade?
CohBar, Inc. (CWBR) trades on the NASDAQ Capital Market.
What sector is CWBR in?
CohBar, Inc. (CWBR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CohBar, Inc.?
Pinchas Cohen Dean, is the chief executive officer of CohBar, Inc. (CWBR).
Where is CohBar, Inc. headquartered?
CohBar, Inc. is headquartered in United States.
Does CWBR pay a dividend?
CohBar, Inc. (CWBR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CWBR go public?
CohBar, Inc. (CWBR) completed its initial public offering in 2017.